Estimates Revisions Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,780.00 ILa | -0.83% |
|
+13.68% | +7.04% |
| 07-30 | Teva CEO on Drug Pipeline, Direct Listing on NYSE | MT |
| 07-29 | Teva Pharmaceutical Industries Limited Reports Unaudited Consolidated Impairment Charges for the Second Quarter Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
